An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00674102 · COMPLETED
Trial details
- NCT number
- NCT00674102
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-03-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.